Skip to main content
Article thumbnail
Location of Repository

Phase II study of helical tomotherapy in the multidisciplinary treatment of oligometastatic colorectal cancer

By Benedikt Engels, Thierry Gevaert, Hendrik Everaert, Peter De Coninck, Alexandra Sermeus, Nicolas Christian, Guy Storme, Dirk Verellen and Mark De Ridder
Topics: Research
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (2007). Actual 10-year survival after resection of colorectal liver metastases defines cure.
    2. (1990). Altendorf-Hofmann A: Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history.
    3. (2004). Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver? Ann Surg Oncol
    4. (2007). European Colorectal Metastases Treatment Group: Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group.
    5. (2010). Final results of the EORTC intergroup randomized study 40004 (CLOCC) evaluating the benefit of radiofrequency ablation (RFA) combined with chemotherapy for Engels et al.
    6. (2009). From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors.
    7. (2010). Futreal PA: The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature
    8. (1993). Gennari L: Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment.
    9. (2011). Geometric accuracy of a novel gimbals based radiation therapy tumor tracking system. Radiother Oncol
    10. (2011). Hellman S: Oligometastases revisited. Nat Rev Clin Oncol
    11. (2010). IacobuzioDonahue CA: Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
    12. (2011). JL: The expanding roles of stereotactic body radiation therapy and oligofractionation: toward a new practice of radiotherapy. Front Radiat Ther Oncol
    13. (1997). MF: Liver resection for colorectal metastases.
    14. (2008). Okunieff P: A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions. Cancer
    15. (2011). Phase II study of helical tomotherapy for oligometastatic colorectal cancer. Ann Oncol
    16. (2010). Randomized phase III study of panitumumab with fluorouracil, leucovorin, and irinotecan (FOLFIRI) compared with FOLFIRI alone as second-line treatment in patients metastatic colorectal cancer.
    17. (2012). Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer. J Thorac Oncol
    18. (2009). Schefter TE: Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases.
    19. (2010). Stereotactic body radiation therapy for colorectal liver metastases.
    20. (2010). Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA
    21. (2007). Storme G: Innovations in image-guided radiotherapy. Nat Rev Cancer
    22. (2009). Thun MJ: Cancer Statistics
    23. (2007). Viele C: The continuum of care: a paradigm for the management of metastatic colorectal cancer. Oncologist
    24. (1995). Weichselbaum RR: Oligometastases.
    25. (2009). YH: Stereotactic body radiation therapy using three fractions for isolated lung recurrence from colorectal cancer. Oncology

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.